Thursday brought fresh analyst coverage on four companies across healthcare and financial services, with most analysts striking an optimistic tone on their new picks.

Leading the bullish calls, Stephens & Co. analyst Raj Kumar initiated coverage on Option Care Health Inc (OPCH) with an Overweight rating and a $40 price target. That represents meaningful upside from where the stock closed Wednesday at $33.09, signaling Kumar sees roughly 21% potential appreciation ahead for the home infusion therapy provider.

Over in the financial sector, Itau BBA analyst Pedro Leduc kicked off coverage on Grupo Supervielle SA – ADR (SUPV) with an Outperform rating and a $15 price target. The Argentine financial services company closed at $10.70 on Wednesday, giving Leduc's target about 40% upside from current levels.

Not every initiation came with fireworks, though. Stephens & Co. analyst Dean Sublett started coverage on Oscar Health Inc (OSCR) with a more cautious Equal-Weight rating and a $17 price target. With shares closing at $15.59 on Wednesday, that suggests Sublett sees modest upside but isn't ready to pound the table just yet on the health insurance technology company.

Rounding out Thursday's coverage initiations, Bernstein analyst William Pickering launched coverage on BridgeBio Pharma Inc (BBIO) with an Outperform rating and an ambitious $94 price target. The biopharmaceutical company closed Wednesday at $72.70, meaning Pickering is projecting roughly 29% upside potential for the stock.

These coverage initiations give investors fresh perspectives on companies that may have been flying under the radar for some analysts. With three out of four earning bullish ratings, it's clear Wall Street sees opportunity in this diverse group spanning healthcare services, insurance technology, biotech, and international banking.